Literature DB >> 842517

Clotrimazole: intermittent therapy in chronic mucocutaneous candidiasis.

M M Ipp, L Boxall, E W Gelfand.   

Abstract

Long-term intermittent therapy with the orally administered antifungal agent, clotrimazole, has not been reported previously. On the basis of experiences with our patient we propose that this is an effective way of treating chronic mucocutaneous candidiasis with a minimum of side effects.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 842517     DOI: 10.1001/archpedi.1977.02120160059009

Source DB:  PubMed          Journal:  Am J Dis Child        ISSN: 0002-922X


  6 in total

1.  The antifungal antibiotic, clotrimazole, inhibits Cl- secretion by polarized monolayers of human colonic epithelial cells.

Authors:  P A Rufo; L Jiang; S J Moe; C Brugnara; S L Alper; W I Lencer
Journal:  J Clin Invest       Date:  1996-11-01       Impact factor: 14.808

Review 2.  An overview of topical antifungal therapy in dermatomycoses. A North American perspective.

Authors:  A K Gupta; T R Einarson; R C Summerbell; N H Shear
Journal:  Drugs       Date:  1998-05       Impact factor: 9.546

3.  Emergence of resistance of Candida albicans to clotrimazole in human immunodeficiency virus-infected children: in vitro and clinical correlations.

Authors:  R Pelletier; J Peter; C Antin; C Gonzalez; L Wood; T J Walsh
Journal:  J Clin Microbiol       Date:  2000-04       Impact factor: 5.948

4.  Candida and "20th-century disease".

Authors:  B Zimmerman; E Weber
Journal:  CMAJ       Date:  1985-11-15       Impact factor: 8.262

5.  The antifungal antibiotic, clotrimazole, inhibits chloride secretion by human intestinal T84 cells via blockade of distinct basolateral K+ conductances. Demonstration of efficacy in intact rabbit colon and in an in vivo mouse model of cholera.

Authors:  P A Rufo; D Merlin; M Riegler; M H Ferguson-Maltzman; B L Dickinson; C Brugnara; S L Alper; W I Lencer
Journal:  J Clin Invest       Date:  1997-12-15       Impact factor: 14.808

Review 6.  Chronic mucocutaneous candidiasis.

Authors:  N Rosman
Journal:  Postgrad Med J       Date:  1979-09       Impact factor: 2.401

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.